Balance Sheet
Accounts PayablesAssetsCommon EquityLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Total Non-Current Liabilities (2023 - 2024)

Lamy (LMMY) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $69595.0 as the latest value for Q3 2024.

  • Quarterly Total Non-Current Liabilities rose 8.85% to $69595.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $69595.0 through Aug 2024, up 8.85% year-over-year, with the annual reading at $68179.0 for FY2024, 9.05% up from the prior year.
  • Total Non-Current Liabilities hit $69595.0 in Q3 2024 for Lamy, up from $68179.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $69595.0 in Q3 2024 to a low of $61111.0 in Q1 2023.